Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-26-083906
Filing Date
2026-07-15
Accepted
2026-07-15 16:30:19
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 tm2619566-4_424b5.htm 424B5 481657
2 GRAPHIC lg_proqrreg-4c.jpg GRAPHIC 17571
3 GRAPHIC fc_pipeline-4clr.jpg GRAPHIC 80777
4 GRAPHIC fc_natural-4clr.jpg GRAPHIC 54475
  Complete submission text file 0001104659-26-083906.txt   693763
Mailing Address ZERNIKEDREEF 9 LEIDEN Netherlands
Business Address ZERNIKEDREEF 9 LEIDEN Netherlands 31 88 166 7000
ProQR Therapeutics N.V. (Filer) CIK: 0001612940 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-297272 | Film No.: 261177686
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)